Table 2.
Characteristics all patients with event (N = 11).
| Sex | Age at OP (Months) |
N-MYC | Stage (INSS) |
Risk | IDRFs (Numbers) |
IME/CME | RD in MRI | Localization | Volume Preop (mL) |
Volume Postop (mL) | Histology | Percentage of Resection | EFS (Months) | Event Localization |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| f | 29 | - | III | i | 3 | IME | + | PT + LN | 92.4 | 15.9 | NB | 82.8 | 16 | L * |
| m | 75 | - | IV | h | 2 | IME | + | PT | 23.7 | 7.4 | NB | 68.8 | 14 | L + M |
| m | 65 | - | III | i | 4 | IME | + | PT | 18.5 | 0.3 | NB | 98.4 | 32 | L |
| m | 86 | - | IV | h | 1 | IME | - | 22.4 | NB | 100.0 | 16 | M * | ||
| f | 51 | - | IV | h | 2 | CME | - | 22.5 | NB | 100.0 | 20 | M * | ||
| f | 59 | - | IV | h | 1 | CME | + | LN | 15.1 | 0.2 | NB | 98.7 | 13 | L + M |
| f | 9 | + | III | h | 2 | CME | + | PT | 1109.8 | 1.2 | NB | 99.9 | 15 | L + M |
| m | 31 | + | IV | h | 2 | CME | - | 2.9 | NB | 100.0 | 24 | L + M * | ||
| f | 126 | - | IV | h | 2 | CME | + | LN | 293.2 | 1.8 | GNB | 99.4 | 12 | L * |
| m | 25 | - | IV | h | 4 | CME | + | LN | 31.6 | 3.6 | GNB | 88.6 | 37 | L + M * |
| m | 5 | - | III | l | 4 | CME | + | LN | 8.3 | 0.9 | GNB | 89.7 | 8 | L + M |
Note: INSS = International Neuroblastoma Staging System; CME = complete macroscopic; IME = incomplete macroscopic excision; IDRFs = image-defined risk factors; RD = residual disease; f = female; m = male; − negative; + positive; l = low; i = intermediate; h = high; LN = lymph node; PT = primary tumor; NB = neuroblastoma; GNB = ganglioneuroblastoma; GN = ganglioneuroma; L + M = local and metastatic; L = local; * = histological confirmed relapse.